Adriani Rossi
Adriani e Rossi started to design and to produce objects for home in 1990, initially for merchandising in the furniture sector.
Artificial Intelligence in Medical Diagnostics Market: Global Market Outlook and Innovations to 2029
Meticulous Research®, a leading global market research company, has published a comprehensive report titled, "AI in Medical Diagnostics Market by Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User (Hospitals, Diagnostic Centers) - Global Forecast to 2029."According to the latest report by Meticulous Research®, the AI in medical diagnostics market is projected to reach a valuation of $9.38 billion by 2029, growing at a robust CAGR of 36.2% from 2022 to 2029. The market's expansion is largely fueled by the increasing necessity for AI integration in medical diagnostics, the shortage of healthcare professionals, and the rising prevalence of chronic diseases. Furthermore, emerging markets and the growing number of cross-industry partnerships and collaborations present substantial growth opportunities for industry players.
However, market growth is anticipated to be hampered by the reluctance to adopt AI technologies due to trust issues, as well as regulatory challenges and concerns surrounding privacy and security.
Download Sample Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5312
Market Segmentation and Key Findings
The AI in medical diagnostics market is segmented by component, specialty, modality, end user, and geography. The report also provides a detailed analysis of key industry competitors and offers country-level market insights.
- Component: The software segment is expected to dominate the market, driven by the demand for AI-powered diagnostic solutions that ensure accurate and timely diagnoses, the launch of new software products, and the growing incidence of acute and chronic diseases, coupled with a shortage of medical specialists.
- Specialty: The brain and neurological segment is anticipated to hold the largest market share, primarily due to the rising prevalence of neurological disorders among the aging population and the introduction of new AI-driven diagnostic tools for brain and neurology applications.
- Modality: The CT scan segment is projected to lead the market in 2022, fueled by the increasing number of patients undergoing CT scans, heightened demand for chest CT scanning during the COVID-19 pandemic, and the growing need for early disease diagnosis.
- End User: Hospitals are expected to account for the largest market share, supported by the high volume of diagnostic imaging procedures conducted in hospitals, the increasing adoption of AI-based solutions by healthcare professionals, and the surge in patient numbers due to the COVID-19 outbreak.
Regional Insights
The report offers a detailed regional analysis covering North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2022, North America is expected to lead the AI in medical diagnostics market, followed by Europe and Asia-Pacific. The region's dominance is attributed to the rapid adoption of AI-based solutions, a significant number of product developments and FDA approvals, and the early implementation of AI-driven platforms across hospitals and diagnostic centers.
Quick Buy – Artificial Intelligence in Medical Diagnostics Market- Opportunity Analysis And Industry Forecast (2022-2029), Research Report: https://www.meticulousresearch.com/Checkout/76337122
Key Industry Players
Prominent players in the AI in medical diagnostics market include Siemens Healthineers AG (Germany), GE Healthcare (U.S.), Aidoc Medical Ltd. (Israel), International Business Machines Corporation (U.S.), AliveCor, Inc. (U.S.), VUNO Inc. (South Korea), Digital Diagnostics Inc. (U.S.), NovaSignal Corp. (U.S.), Riverain Technologies (U.S.), NANO-X IMAGING LTD (Israel), Imagen Technologies (U.S.), Koninklijke Philips N.V. (Netherlands), Agfa-Gevaert Group (Belgium), HeartFlow, Inc. (U.S.), and Arterys Inc. (U.S.).
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Please login to comment on this Post